The rapid development and deployment of COVID-19 vaccines marked a pivotal moment in the global response to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic. Among the most widely used vaccines were the mRNA-1273 (Spikevax®) from Moderna and BNT 162b2 (Comirnaty®) from Pfizer-BioNTech, authorized in January 2021 and December 2020, respectively. These vaccines played … Leggi tutto Adverse Effects of COVID-19 mRNA Vaccines: A Focus on Chronic Urticaria in Switzerland